Newtyn Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-700,000
Closed -$6.38M 39
2025
Q2
$6.38M Buy
+700,000
New +$5.15M 0.97% 24

Other funds holding SAGE